I am focused on the molecular mechanisms of resistance to conventional chemotherapy in bladder cancer, as well as on the identification of new biomarkers as potential targets to sensitize to the treatment and improve clinical outcomes. To this end, I have been working with several molecular biology techniques both in tumor cell lines and in patient biopsies, and I have also acquired some experience in handling animal models.
I am focused on the molecular mechanisms of resistance to conventional chemotherapy in bladder cancer, as well as on the identification of new biomarkers as potential targets to sensitize to the treatment and improve clinical outcomes. To this end, I have been working with several molecular biology techniques both in tumor cell lines and in patient biopsies, and I have also acquired some experience in handling animal models.